injection site for tirzepatide reaction : r/tirzepatidecompound Comprehensive Guide To Subcutaneous Self-Injection

Magnsdttir et al., 2015)

Lexarias' DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound As previously announced, oral DehydraTECH-tirzepatide also reduced adverse events by 47% compared to injected Zepbound Lexarias oral capsules worthy of expanded investigation as a viable alternative to injected tirzepatide

Side effects are rare, and because the body already recognizes these molecules, negative reactions are minimal

[DOI] [PubMed] [Google Scholar] 37.Gettys TW, Harkness PJ, Watson PM

JSTOR 1227417